标题
Natural Killer T Cells in Cancer Immunotherapy
作者
关键词
-
出版物
Frontiers in Immunology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-09-22
DOI
10.3389/fimmu.2017.01178
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type II NKT Cells and Their Emerging Role in Health and Disease
- (2017) Madhav V. Dhodapkar et al. JOURNAL OF IMMUNOLOGY
- Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
- (2017) Laura Escribà-Garcia et al. Journal of Translational Medicine
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
- (2017) Christian W. Keller et al. Frontiers in Immunology
- Hallmarks of Tissue-Resident Lymphocytes
- (2016) Xiying Fan et al. CELL
- Non-glycosidic compounds can stimulate both human and mouseiNKT cells
- (2016) John-Paul Jukes et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunotherapeutic strategies targeting natural killer T cell responses in cancer
- (2016) Susannah C. Shissler et al. IMMUNOGENETICS
- Activation strategies for invariant natural killer T cells
- (2016) Ayano C. Kohlgruber et al. IMMUNOGENETICS
- CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
- (2016) Gengwen Tian et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells
- (2016) Kyle K. Payne et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
- (2016) Shiny Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
- (2016) Shuichi Kitayama et al. Stem Cell Reports
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
- (2016) Linnea Veinotte et al. OncoImmunology
- Co-operation of -galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model
- (2015) T. Dong et al. BIOCHEMICAL JOURNAL
- Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional
- (2015) Wenji Sun et al. CYTOKINE
- Tissue-Specific Distribution of iNKT Cells Impacts Their Cytokine Response
- (2015) You Jeong Lee et al. IMMUNITY
- The burgeoning family of unconventional T cells
- (2015) Dale I Godfrey et al. NATURE IMMUNOLOGY
- A new mouse strain for the analysis of invariant NKT cell function
- (2015) Shilpi Chandra et al. NATURE IMMUNOLOGY
- Synthesis and Activity of 6″-Deoxy-6″-thio-α-GalCer and Peptide Conjugates
- (2015) Benjamin J. Compton et al. ORGANIC LETTERS
- The Regulatory Role of Invariant NKT Cells in Tumor Immunity
- (2015) Rosanna M. McEwen-Smith et al. Cancer Immunology Research
- Antitumor Responses of Invariant Natural Killer T Cells
- (2015) Jennie B. Altman et al. Journal of Immunology Research
- The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8+ T Cell Generation
- (2015) Catherine Gottschalk et al. Frontiers in Immunology
- The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions
- (2015) Elodie Macho-Fernandez et al. Frontiers in Immunology
- Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer
- (2015) Idania Marrero et al. Frontiers in Immunology
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Biology of CD1- and MR1-Restricted T Cells
- (2014) Mariolina Salio et al. Annual Review of Immunology
- An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
- (2014) J. D. Gibbins et al. BLOOD
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
- (2014) S. Nair et al. BLOOD
- Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
- (2014) Haneen Nur et al. BRITISH JOURNAL OF HAEMATOLOGY
- Optimization of Natural Killer T Cell–Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
- (2014) C. Faveeuw et al. CANCER RESEARCH
- iNKT Cells: Innate Lymphocytes with a Diverse Response
- (2014) Marta Monteiro et al. CRITICAL REVIEWS IN IMMUNOLOGY
- iNKT-cell help to B cells: A cooperative job between innate and adaptive immune responses
- (2014) Paolo Dellabona et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis
- (2014) Ivan J Fuss et al. GUT
- Optimizing NKT cell ligands as vaccine adjuvants
- (2014) Leandro J Carreño et al. Immunotherapy
- IL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
- (2014) Duygu Sag et al. JOURNAL OF CLINICAL INVESTIGATION
- CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
- (2014) Tsung Wen Chong et al. JOURNAL OF CLINICAL PATHOLOGY
- Involvement of Secretory and Endosomal Compartments in Presentation of an Exogenous Self-Glycolipid to Type II NKT Cells
- (2014) K. C. Roy et al. JOURNAL OF IMMUNOLOGY
- Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells
- (2014) V. Y. Taraban et al. JOURNAL OF IMMUNOLOGY
- NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis
- (2014) J. A. Berzofsky et al. JOURNAL OF IMMUNOLOGY
- Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells
- (2014) E. Germanov et al. JOURNAL OF IMMUNOLOGY
- Role and Regulation of CD1d in Normal and Pathological B Cells
- (2014) Mohammed S. Chaudhry et al. JOURNAL OF IMMUNOLOGY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
- (2014) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NKT Cell Networks in the Regulation of Tumor Immunity
- (2014) Faith C. Robertson et al. Frontiers in Immunology
- Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
- (2014) Jie Zhao et al. OncoImmunology
- Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells
- (2013) Daofeng Liu et al. CLINICAL IMMUNOLOGY
- Transcriptional regulation of the NKT cell lineage
- (2013) Michael G Constantinides et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
- (2013) Sungyoul Hong et al. IMMUNOLOGY LETTERS
- CD1d expression as a prognostic marker for chronic lymphocytic leukemia
- (2013) Athanasios Anastasiadis et al. LEUKEMIA & LYMPHOMA
- CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis
- (2013) Agnieszka Bojarska-Junak et al. LEUKEMIA RESEARCH
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs
- (2013) R. V. V. Tatituri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- iNKT Cell Cytotoxic Responses Control T-Lymphoma Growth In Vitro and In Vivo
- (2013) H. Bassiri et al. Cancer Immunology Research
- Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity
- (2013) Aleksandra M. Dudek et al. Frontiers in Immunology
- Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells
- (2012) Sebastian Zeissig et al. Annals of the New York Academy of Sciences
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Invariant NKT cells increase drug-induced osteosarcoma cell death
- (2012) S Fallarini et al. BRITISH JOURNAL OF PHARMACOLOGY
- CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
- (2012) Stéphanie Corgnac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
- (2012) Karsten A. Pilones et al. Clinical & Developmental Immunology
- Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells
- (2012) Enrico Girardi et al. IMMUNOLOGICAL REVIEWS
- Incorporation of polyinosine–polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex
- (2012) Takashi Nakamura et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia
- (2012) Alicia E. Najera Chuc et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells
- (2012) Kaoru Nagato et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
- (2012) Famke L. Schneiders et al. JOURNAL OF CLINICAL ONCOLOGY
- CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1-Dependent Regulation of Type 1 Diabetes
- (2012) N. Kadri et al. JOURNAL OF IMMUNOLOGY
- Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells
- (2012) Nadia R Cohen et al. NATURE IMMUNOLOGY
- Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor
- (2012) Onisha Patel et al. NATURE IMMUNOLOGY
- Lower TCR repertoire diversity in Traj18-deficient mice
- (2012) Romain Bedel et al. NATURE IMMUNOLOGY
- Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens
- (2012) Enrico Girardi et al. NATURE IMMUNOLOGY
- iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
- (2012) Ryan L. Bjordahl et al. PLoS One
- Immunomodulatory Type II Natural Killer T Lymphocytes in Health and Disease
- (2012) S. Rhost et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
- (2011) L. G. Durrant et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
- (2011) Shinichiro Motohashi et al. CLINICAL IMMUNOLOGY
- Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: Reversing tumor-induced defects
- (2011) Mark A. Exley et al. CLINICAL IMMUNOLOGY
- Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection
- (2011) Manfred Brigl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion Injury
- (2011) S. H. Yang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
- (2011) Laura M. Hix et al. PLoS One
- Differential requirements for the Ets transcription factor Elf-1 in the development of NKT cells and NK cells
- (2010) H.-J. Choi et al. BLOOD
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
- (2010) Leonid S. Metelitsa CLINICAL IMMUNOLOGY
- The presence of CD8+ invariant NKT cells in mice
- (2010) Hyunji Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Transcriptional control of invariant NKT cell development
- (2010) Rupali Das et al. IMMUNOLOGICAL REVIEWS
- Potent anti-tumor responses to immunization with dendritic cells loaded with tumor tissue and an NKT cell ligand
- (2010) Troels R Petersen et al. IMMUNOLOGY AND CELL BIOLOGY
- Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
- (2010) Hiroshi Watarai et al. JOURNAL OF CLINICAL INVESTIGATION
- Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
- (2010) G. Wingender et al. JOURNAL OF IMMUNOLOGY
- CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
- (2010) S. Miura et al. JOURNAL OF VIROLOGY
- Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs
- (2010) Verena Semmling et al. NATURE IMMUNOLOGY
- Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
- (2010) Carmela De Santo et al. NATURE IMMUNOLOGY
- The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage
- (2010) Taishan Hu et al. NATURE IMMUNOLOGY
- Raising the NKT cell family
- (2010) Dale I Godfrey et al. NATURE IMMUNOLOGY
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a -linked self-glycolipid
- (2010) P. Arrenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
- (2010) Daejin Kim et al. VACCINE
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
- (2009) K. A. Pilones et al. CLINICAL CANCER RESEARCH
- Natural Killer T Cells and Autoimmune Disease
- (2009) Lan Wu et al. CURRENT MOLECULAR MEDICINE
- The Contrasting Roles of NKT Cells in Tumor Immunity
- (2009) Jay Berzofsky et al. CURRENT MOLECULAR MEDICINE
- Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells
- (2009) Maria Blomqvist et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
- (2009) D. Bagnara et al. HAEMATOLOGICA
- Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors
- (2009) Daniel G. Pellicci et al. IMMUNITY
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- CD1d Activation and Blockade: A New Antitumor Strategy
- (2009) M. W. L. Teng et al. JOURNAL OF IMMUNOLOGY
- CD1d-Based Combination Therapy Eradicates Established Tumors in Mice
- (2009) M. W. L. Teng et al. JOURNAL OF IMMUNOLOGY
- Selective Requirement for c-Myc at an Early Stage of V 14i NKT Cell Development
- (2009) M. P. Mycko et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Mechanisms for Glycolipid Antigen-Driven Cytokine Polarization by Vα14 i NKT Cells
- (2009) Barbara A. Sullivan et al. JOURNAL OF IMMUNOLOGY
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- Intrathymic proliferation wave essential for V 14+ natural killer T cell development depends on c-Myc
- (2009) M. Dose et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen recognition by CD1d-restricted NKT T cell receptors
- (2009) Dale I. Godfrey et al. SEMINARS IN IMMUNOLOGY
- Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
- (2009) Manjunatha M. Venkataswamy et al. SEMINARS IN IMMUNOLOGY
- Regulation of multiple myeloma survival and progression by CD1d
- (2008) E. Spanoudakis et al. BLOOD
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
- (2008) D. H. Chang et al. BLOOD
- CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune system
- (2008) Jennifer L Matsuda et al. CURRENT OPINION IN IMMUNOLOGY
- Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival
- (2008) Angela Shaulov et al. EXPERIMENTAL HEMATOLOGY
- The Transcription Factor PLZF Directs the Effector Program of the NKT Cell Lineage
- (2008) Adam K. Savage et al. IMMUNITY
- α-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity
- (2008) Yeon-Jeong Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens
- (2008) Philomena Arrenberg et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice
- (2008) Kathrin Stirnemann et al. JOURNAL OF CLINICAL INVESTIGATION
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- The BTB–zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions
- (2008) Damian Kovalovsky et al. NATURE IMMUNOLOGY
- Critical role of ROR- t in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
- (2008) M.-L. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK T cells provide lipid antigen-specific cognate help for B cells
- (2008) E. A. Leadbetter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo
- (2008) P. Barral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started